Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Codexis is a biotechnology company specializing in enzyme engineering and biocatalysis for pharmaceutical manufacturing and RNAi therapeutics. Its proprietary CodeEvolver platform develops high-performance enzymes to improve drug synthesis efficiency, yield, and sustainability. The company offers enzymatic solutions, contract development, and manufacturing services, targeting large pharma clients and the growing RNAi market with a focus on scalable, environmentally friendly processes.
This description was generated via AI from an annual report. Updated about 1 year ago.